Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...
Pfizer's drug approvals and advertising revenue could be affected by RFK Jr.'s potential appointment. See why PFE stock is a ...
Meanwhile, Russia reports interest in its mpox vaccine from African and former Soviet countries, indicating ongoing global ...
AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.
How has the relationship between Big Pharma and biotech evolved? And where do CROs fit into the mix? Dearth of VC funding forcing difficult biotech decisions The realities of the global economy ...
Shyra Gardai, chief scientific officer at the molecular glue start-up EpiBiologics, says Big Pharma’s recent interest in glue ...
In a recent interview, Mr. Trump said that Mr. Kennedy wanted to reform a host of issues relating to Big Pharma’s ...
If you bought even just a bar of bath soap last year, you contributed to the wellness industry—and a new report released ...
Lower Manhattan-based Metsera is one of the latest drug startups to throw its hat into the ring with the pharma giants ...
The FDA's Dr. Peter Marks says he hopes to keep his job under a second Trump term, and urges Robert F. Kennedy Jr. to "keep ...